Economy Local February 15, 2025

Alfaparf Milano Expands Investment in Argentina

Alfaparf Milano plans to double its revenue in Argentina by investing $2 million and expanding its product portfolio in the mass market sector over the next three years.


Alfaparf Milano Expands Investment in Argentina

The company Alfaparf Milano aims to double its revenue in the next three years with an investment of $2 million and the expansion of its portfolio in the mass market. Cantero, the company's representative, expressed that this decision aligns with what Alfaparf does in more than 120 countries where it operates.

With an investment of $175 million, the company will strengthen its presence in the mass consumption segment in Argentina and plans to double its monthly revenue from $1.5 million to $3 million in the next three years. Cantero pointed out that the group seeks to expand in the mass market, where they already have significant clients.

The acquisition of new brands such as Depil Bella and Raavi, and the opening to white label production, reflect Alfaparf Milano's growth strategy. The plant in Argentina, which has been operating for 12 years, will adjust its operations to adapt to this new product offering.

More than 150 employees in Argentina work in all operational areas of the company, including the laboratory and the production plant. The shift in the balance between national and imported products implies a restructuring in Alfaparf's production strategy.

Cantero detailed that the $2 million investment will be allocated to expanding the company's portfolio in Argentina. The Italian multinational group has incorporated significant brands into its offering, strengthening its presence in the international cosmetic industry market.

The company projects to close the year with a 25% growth in its annual revenue and is prepared to explore new segments, such as hair removal. Alfaparf Milano's global expansion strategy responds to its goal of being one of the leading players in the cosmetic industry worldwide.

Latest news

See all news